Biodistribution of the chimeric monoclonal antibody U36 radioiodinated with a closo-dodecaborate-containing linker. Comparison with other radioiodination methods

Bioconjugate Chemistry

Volumn 14, Issue 4, 2003, Pages 805-810

  Nestor, Marika ^a,c   Persson, Mikael ^a   Cheng, Junping ^a   Tolmachev, Vladimir ^a   Van Dongen, Guus ^b   Anniko, Matti ^a   Kairemo, Kalevi ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODIES;

4-IODOBENZOATE; BIODISTRIBUTIONS; BIOLOGICAL PROPERTIES; CHLORAMINE-T; IN-VITRO; IN-VIVO; LABELINGS; LINKER MOLECULES; MOLAR RATIO; RADIOIODINATION;

MOLECULES;

(4 ISOTHIOCYANATOBENZYLAMMONIO)UNDECAHYDRODODECABORATE; CHIMERIC ANTIBODY; IODINE 125; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY U36; N SUCCINIMIDYL 4 IODOBENZOATE; TOSYLCHLORAMIDE SODIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY AFFINITY; ANTIBODY LABELING; ARTICLE; DRUG CONJUGATION; DRUG DISTRIBUTION; DRUG SPECIFICITY; FEMALE; HALOGENATION; HUMAN; HUMAN CELL; ISOTOPE LABELING; MOUSE; NONHUMAN; RADIOIMMUNOTHERAPY; RADIOIODINATION;

ANIMALIA;

EID: 0038793484     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc034003n     Document Type: Article

References (39)

1. Potamianos, S., Varvarigou, A. D., and Archimandritis, S. C. (2000) Radioimmunoscintigraphy and radioimmunotherapy in cancer: principles and application. Anticancer Res. 20, 925-948.
2. Tolmachev, V., and Sjöberg, S. (2002) Polyhedral boron compounds as potential linkers for attachment of radiohalogens to targeting proteins and peptides. A review. Collect Czech. Chem. Commun. 67, 913-935.
3. van Deurs, B., Petersen, O. W., Olsnes, S., and Sandvig, K. (1989) The ways of endocytosis. Int. Rev. Cytol. 117, 131-177.
4. Kyriakos, R. J., Shih, L. B., Ong, G. L., Patel, K., Goldenberg, D. M., and Mattes, M. J. (1992) The fate of antibodies bound to the surface of tumor cells in vitro. Cancer Res. 52, 835-842.
5. Geissler, F., Anderson, S. K., Venkatesan, P., and Press, O. (1992) Intracellular catabolism of radiolabeled anti-mu antibodies by malignant B-cells. Cancer Res. 52, 2907-2915.
6. Press, O. W., Shan, D., Howell-Clark, J., Eary, J., Appelbaum, F. R., Matthews, D., King, D. J., Haines, A. M., Hamann, P., Hinman, L., Shochat, D., and Bernstein, I. D. (1996) Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells. Cancer Res. 56, 2123-2129.
7. Stein, R., Goldenberg, D. M., Thorpe, S. R., and Mattes, M. J. (1997) Advantage of a residualizing iodine radiolabel for radioimmunotherapy of xenografts of human nonsmall-cell carcinoma of the lung. J. Nucl. Med. 38, 391-395.
8. Nikula, T. K., Bocchia, M., Curcio, M. J., Sgouros, G., Ma, Y., Finn, R. D., and Scheinberg, D. A. (1995) Impact of the high tyrosine fraction in complementarity determining regions: measured and predicted effects of radioiodination on IgG immunoreactivity. Mol. Immunol. 32, 865-872.
9. Wilbur, D. S., Hadley, S. W., Hylarides, M. D., Abrams, P. G., Beaumier, P. A., Morgan, A. C., Reno, J. M., and Fritzberg, A. R. (1989) Development of a stable radioiodinating reagent to label monoclonal antibodies for radiotherapy of cancer. J. Nucl. Med. 30, 216-226.
10. Zalutsky, M. R., and Narula, A. S. (1987) A method for the radiohalogenation of proteins resulting in decreased thyroid uptake of radioiodine. Int. J. Radiat. Appl. Instrum. [A] 38, 1051-1055.
11. Zalutsky, M. R., and Narula, A. S. (1988) Radiohalogenation of a monoclonal antibody using an N-succinimidyl 3-(tri-n-butylstannyl)benzoate intermediate. Cancer Res. 48, 1446-1450.
12. Zalutsky, M. R., Noska, M. A., Colapinto, E. V., Garg, P. K., and Bigner, D. D. (1989) Enhanced tumor localization and in vivo stability of a monoclonal antibody radioiodinated using N-succinimidyl 3-(tri-n-butylstannyl)benzoate. Cancer Res. 49, 5543-5549.
13. 76Br-labelled Monoclonal Antibodies for PET. Preclinical Evaluation of Halogenated Antibodies for Diagnosis and Treatment of Cancer. Acta Univ. Ups., Uppsala Diss. Fac. Med.
14. Wilbur, D. S., Hadley, S. W., Grant, L. M., and Hylarides, M. D. (1991) Radioiodinated iodobenzoyl conjugates of a monoclonal antibody Fab fragment. In vivo comparisons with chloramine-T-labeled Fab. Bioconjugate Chem. 2, 111-116.
15. Vaidyanathan, G., Affleck, D. J., Li, J., Welsh, P., and Zalutsky, M. R. (2001) A polar substituent-containing acylation agent for the radioiodination of internalizing monoclonal antibodies: N-succinimidyl 4-guanidinomethyl-3-[131I]iodobenzoate ([131I]SGMIB). Bioconjugate Chem. 12, 428-438.
16. Behr, T. M., Becker, W. S., Sharkey, R. M., Juweid, M. E., Dunn, R. M., Bair, H. J., Wolf, F. G., and Goldenberg, D. M. (1996) Reduction of renal uptake of monoclonal antibody fragments by amino acid infusion. J. Nucl. Med. 37, 829-833.
17. Behr, T. M., Sharkey, R. M., Juweid, M. E., Blumenthal, R. D., Dunn, R. M., Griffiths, G. L., Bair, H. J., Wolf, F. G., Becker, W. S., and Goldenberg, D. M. (1995) Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives. Cancer Res. 55, 3825-3834.
18. Tolmachev, V., Lundqvist, H., Carlsson, J., Sivaev, I., Orlova, A., and Sundin, A. (1997) Labeling and in vivo evaluation of closo-dodecaborate as a linker for attachment of iodine to radiopharmaceuticals. J. Labelled Compd. Radiopharm. 40, 125.
19. Orlova, A., Sivaev, I., Sjoberg, S., and Tolmachev, V. (2001) Radioiodination of monocarboranes. 2nd Eur. Symp. Boron Chem. (EUROBORON 2), (Book of Abstracts) 33.
20. Tolmachev, V., Koziorowski, J., Sivaev, I., Lundqvist, H., Carlsson, J., Orlova, A., Gedda, L., Olsson, P., Sjoberg, S., and Sundin, A. (1999) Closo-dodecaborate(2-) as a linker for iodination of macromolecules. Aspects on conjugation chemistry and biodistribution. Bioconjugate Chem. 10, 338-345.
21. Orlova, A., Tolmachev, V., and Lundqvist, H. (2000) Closododecaborate (2-) anion as a potential prosthetic group for attachment of radioiodine to proteins. Aspects of labeling chemistry in aqueous solutions. Eur. J. Nucl. Med. 27, 1210.
22. Tolmachev, V., Bruskin, A., Sivaev, I., Lundqvist, H., and Sjoberg, S. (2001) Oxidative radiobromination of the dodecahydro-closo-dodecaborate (2-) anion. 2nd Eur. Symp. Boron Chem. (EUROBORON 2), (Book of Abstracts) 55.
23. Tolmachev, V., Bruskin, A., Winberg, K. J., Sivaev, I., Persson, M., Lundqvist, H., Sjoberg, S., and Carlsson, J. (2002) The use of derivatives of polyhedral boron anions (PHA), closo-dodecaborate and nido-carborate, for radiobromination of anti-HER-2 antibody Herceptin for immunoPET. (Abstracts of the 15th meeting of the International Research Group in Immunoscintigraphy and Immunotherapy (IRIST), Rotterdam, The Netherlands, May 24-25 May, 2002) Cancer Biother. Radiopharm. 17, 353-354.
24. Tolmachev, V., Orlova, A., Bruskin, A., Sivaev, I., Persson, M., Sjoberg, S., Carlsson, J., and Lundqvist, H. (2002) The use of benzyl isothiocyanate derivative of closo-dodecaborate dianion for indirect radioiodination and radiobromination of monoclonal antibodies. Eur. J. Nucl. Med. 29, Supplement 1: S76.
25. Colnot, D. R., Ossenkoppele, J. C., Quak, J. J., de Bree, R., Börjesson, P. C., Snow, G. B., and van Dongen, G. A. (2002) Re-infusion of Unprocessed, G.-CSF-Stimulated Whole Blood Allows Dose Escalation of 186-Re-cMAb U36 Radioimmunotherapy in a Phase I Dose Escalation Study. Clin. Cancer Res. 8, 3401-3406.
26. Colnot, D. R., Quak, J. J., Roos, J. C., de Bree, R., Wilhelm, A. J., Snow, G. B., and van Dongen, G. A. (2001) Radioimmunotherapy in patients with head and neck squamous cell carcinoma: initial experience. Head Neck 23, 559-565.
27. Colnot, D. R., Quak, J. J., Roos, J. C., van Lingen, A., Wilhelm, A. J., van Kamp, G. J., Huijgens, P. C., Snow, G. B., and van Dongen, G. A. (2000) Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck, J. Nucl. Med. 41, 1999-2010.
28. Van Hal, N. L., Van Dongen, G. A., Rood-Knippels, E. M., Van Der Valk, P., Snow, G. B., and Brakenhoff, R. H. (1996) Monoclonal antibody U36, a suitable candidate for clinical immunotherapy of squamous-cell carcinoma, recognizes a CD44 isoform. Int. J. Cancer 68, 520-527.
29. de Bree, R., Roos, J. C., Quak, J. J., den Hollander, W., Snow, G. B., and van Dongen, G. A. (1995) Radioimmunoscintigraphy and biodistribution of technetium-99m-labeled monoclonal antibody U36 in patients with head and neck cancer. Clin. Cancer Res. 1, 591-598.
30. Vrouenraets, M. B., Visser, G. W. M., Stigter, M., Oppelaar, H., Snow, G. B., and van Dongen, G. A. M. S. (2001) Targeting of Aluminum (III) Phthalocyanine Tetrasulfonate by Use of Internalizing Monoclonal Antibodies: Improved Efficacy in Photodynamic Therapy. Cancer Res. 61, 1970-1975.
31. Vrouenraets, M. B., Visser, G. W., Loup, C., Meunier, B., Stigter, M., Oppelaar, H., Stewart, F. A., Snow, G. B., and van Dongen, G. A. (2000) Targeting of a hydrophilic photosensitizer by use of internalizing monoclonal antibodies: A new possibility for use in photodynamic therapy. Int. J. Cancer 88, 108-114.
32. Schrijvers, A. H., Quak, J. J., Uyterlinde, A. M., van Walsum, M., Meijer, C. J., Snow, G. B., and van Dongen, G. A. (1993) MAb U36, a novel monoclonal antibody successful in immunotargeting of squamous cell carcinoma of the head and neck. Cancer Res. 53, 4383-4390.
33. van Gog, F. B., Brakenhoff, R. H., Stigter-van Walsum, M., Snow, G. B., and van Dongen, G. A. (1998) Perspectives of combined radioimmunotherapy and anti-EGFR antibody therapy for the treatment of residual head and neck cancer. Int. J. Cancer 77, 13-18.
34. van Gog, F. B., Visser, G. W., Stroomer, J. W., Roos, J. C., Snow, G. B., and van Dongen, G. A. (1997) High dose rhenium-186-labeling of monoclonal antibodies for clinical application: pitfalls and solutions. Cancer 80, 2360-2370.
35. Brakenhoff, R. H., van Gog, F. B., Looney, J. E., van Walsum, M., Snow, G. B., and van Dongen, G. A. (1995) Construction and characterization of the chimeric monoclonal antibody E48 for therapy of head and neck cancer. Cancer Immunol. Immunother. 40, 191-200.
36. Koziorowski, J., Henssen, C., and Weinreich, R. (1998) A new convenient route to radioiodinated N-succinimidyl 3- and 4-iodobenzoate, two reagents for radioiodination of proteins. Appl. Radiat. Isot. 49, 955-959.
37. -: A New Route to Water Soluble Agents for BNCT. Inorg. Chem. 38, 5887-5893.
38. Henderson, L. A., Baynes, J. W., and Thorpe, S. R. (1982) Identification of the sites of IgG catabolism in the rat. Arch. Biochem. Biophys. 215, 1-11.
39. Moldoveanu, Z., Epps, J. M., Thorpe, S. R., and Mestecky, J. (1988) The sites of catabolism of murine monomeric IgA. J. Immunol. 141, 208-213.